T. Rowe Price Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $980K | Buy |
|
|||||
|
2025
Q2 | $1.19M | Buy |
|
|||||
|
2025
Q1 | $934K | Sell |
|
|||||
|
2024
Q4 | $8.38M | Buy |
|
|||||
|
2024
Q3 | $20.2M | Sell |
|
|||||
|
2024
Q2 | $13.8M | Buy |
|
|||||
|
2024
Q1 | $23.5M | Buy |
|
|||||
|
2023
Q4 | $21.2M | Buy |
|
|||||
|
2023
Q3 | $17.4M | Sell |
|
|||||
|
2023
Q2 | $25.8M | Buy |
|
|||||
|
2023
Q1 | $27.4M | Sell |
|
|||||
|
2022
Q4 | $23.8M | Buy |
|
|||||
|
2022
Q3 | $27.1M | Buy |
|
|||||
|
2022
Q2 | $1.16M | Buy |
|
|||||
|
2022
Q1 | $1.11M | Buy |
|
|||||
|
2021
Q4 | $831K | Sell |
|
|||||
|
2021
Q3 | $1.09M | Sell |
|
|||||
|
2021
Q2 | $772K | Sell |
|
|||||
|
2021
Q1 | $752K | Sell |
|
|||||
|
2020
Q4 | $661K | Buy |
|
|||||
|
2020
Q3 | $413K | Sell |
|
|||||
|
2020
Q2 | $373K | Sell |
|
|||||
|
2020
Q1 | $309K | Buy |
|
|||||
|
2019
Q4 | $507K | Buy |
|
|||||
|
2019
Q3 | $141K | Buy |
|
|||||
|
2019
Q2 | $153K | Buy |
|
|||||
|
2019
Q1 | $238K | Buy |
|
|||||
|
2018
Q4 | $373K | Buy |
|
|||||
|
2018
Q3 | $522K | Buy |
|
|||||
|
2018
Q2 | $374K | Sell |
|
|||||
|
2018
Q1 | $326K | Buy |
|
|||||
|
2017
Q4 | $278K | Buy |
|
|||||
|
2017
Q3 | $281K | Buy |
|
|||||
|
2017
Q2 | $398K | Sell |
|
|||||
|
2017
Q1 | $371K | Buy |
|
|||||
|
2016
Q4 | $246K | Buy |
|